Definitive Healthcare Appoints Kevin Coop As CEO, Effective June 24, 2024

5/28/24 8:15:02 AM ET

Computer Software: Prepackaged Software

Technology

Get the next $DH alert in real time by email

Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that its Board of Directors has appointed Kevin Coop as the Company's next Chief Executive Officer and as a member of the Board of Directors, each effective June 24, 2024. Mr. Coop succeeds Jason Krantz, founder and Executive Chairman, who has been serving as Interim CEO since January 2024. Mr. Krantz will continue to serve on the Board of Directors as Executive Chairman after the CEO transition.

Get the next $DH alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$DH

Date	Price Target	Rating	Analyst
5/9/2025		Buy → Neutral	BTIG Research
1/13/2025	$4.00	Equal Weight → Underweight	Barclays
12/20/2024	$5.00	Equal-Weight	Stephens
9/17/2024	$7.00	Buy	BTIG Research
7/31/2024	$7.00 → $5.00	Neutral → Underweight	JP Morgan
5/8/2024	$11.50 → $9.00	Overweight → Equal-Weight	Morgan Stanley
1/17/2024		Buy → Hold	Needham
1/5/2024		Buy → Hold	Canaccord Genuity

More analyst ratings

$DH
Press Releases

Fastest customizable press release news feed in the world

Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
FRAMINGHAM, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (NASDAQ:DH), an industry leader in healthcare market data and analytics, today announced that in connection with the hiring of a senior leader, that the Human Capital Management and Compensation Committee (the "Committee") of Definitive Healthcare's Board of Directors granted an inducement award. The Committee granted Tina Hannagan, Definitive Healthcare's Chief Commercial Officer, an inducement award consisting of 830,565 time-based restricted stock units ("RSUs") effective June 1, 2025. This award was individually negotiated and was granted as an inducement material to Ms. Hannagan's commencement of employment wit
6/3/25 8:00:00 AM ET
$DH
Computer Software: Prepackaged Software
Technology
Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025
FRAMINGHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended March 31, 2025. First Quarter 2025 Financial Highlights: Revenue was $59.2 million, a decrease of 7% from $63.5 million in Q1 2024. Net Loss, inclusive of goodwill impairment charges of $176.5 million, was $(155.1) million, or (262)% of revenue, compared to $(12.7) million or (20)% of revenue in Q1 2024. Adjusted Net Income was $7.0 million, compared to $13.0 million in Q1 2024. Adjusted EBITDA was $14.7 million, or 25% of revenue, compar
5/8/25 4:05:00 PM ET
$DH
Computer Software: Prepackaged Software
Technology
Definitive Healthcare Announces Timing of Its First Quarter 2025 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its first quarter ended March 31, 2025, on Thursday, May 8, 2025 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results. A live audio webcast of the event will be available on the Definitive Healthcare's Investor Relations website at https://ir.definitivehc.com/. A live dial-in will be available at 877-358-7298 (domestic) or +1-848-488-9244 (international). Shortly
4/24/25 4:05:00 PM ET
$DH
Computer Software: Prepackaged Software
Technology

$DH
Financials

Live finance-specific insights

Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025
FRAMINGHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended March 31, 2025. First Quarter 2025 Financial Highlights: Revenue was $59.2 million, a decrease of 7% from $63.5 million in Q1 2024. Net Loss, inclusive of goodwill impairment charges of $176.5 million, was $(155.1) million, or (262)% of revenue, compared to $(12.7) million or (20)% of revenue in Q1 2024. Adjusted Net Income was $7.0 million, compared to $13.0 million in Q1 2024. Adjusted EBITDA was $14.7 million, or 25% of revenue, compar
5/8/25 4:05:00 PM ET
$DH
Computer Software: Prepackaged Software
Technology
Definitive Healthcare Announces Timing of Its First Quarter 2025 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its first quarter ended March 31, 2025, on Thursday, May 8, 2025 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results. A live audio webcast of the event will be available on the Definitive Healthcare's Investor Relations website at https://ir.definitivehc.com/. A live dial-in will be available at 877-358-7298 (domestic) or +1-848-488-9244 (international). Shortly
4/24/25 4:05:00 PM ET
$DH
Computer Software: Prepackaged Software
Technology
Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2024
FRAMINGHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights: Revenue was $62.3 million, a decrease of 6% from $65.9 million in Q4 2023. Net Loss, inclusive of goodwill impairment charges of $97.1 million, was $(84.7) million, or (136)% of revenue, compared to $(13.4) million or (20)% of revenue in Q4 2023. Adjusted Net Income was $12.6 million, compared to $10.6 million in Q4 2023. Adjusted EBITDA was $17.5 million, or 28%
2/27/25 4:05:53 PM ET
$DH
Computer Software: Prepackaged Software
Technology

Definitive Healthcare Appoints Kevin Coop As CEO, Effective June 24, 2024

Chat with this insight

Recent Analyst Ratings for
$DH

$DH
SEC Filings

SEC Form 8-K filed by Definitive Healthcare Corp.

Amendment: SEC Form SCHEDULE 13G/A filed by Definitive Healthcare Corp.

SEC Form SCHEDULE 13G filed by Definitive Healthcare Corp.

$DH
Press Releases

Fastest customizable press release news feed in the world

Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025

Definitive Healthcare Announces Timing of Its First Quarter 2025 Financial Results Conference Call and Webcast

$DH
Financials

Live finance-specific insights

Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025

Definitive Healthcare Announces Timing of Its First Quarter 2025 Financial Results Conference Call and Webcast

Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2024

Definitive Healthcare Appoints Kevin Coop As CEO, Effective June 24, 2024

Chat with this insight

Recent Analyst Ratings for $DH

$DH SEC Filings

SEC Form 8-K filed by Definitive Healthcare Corp.

Amendment: SEC Form SCHEDULE 13G/A filed by Definitive Healthcare Corp.

SEC Form SCHEDULE 13G filed by Definitive Healthcare Corp.

$DH Press Releases

Fastest customizable press release news feed in the world

Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025

Definitive Healthcare Announces Timing of Its First Quarter 2025 Financial Results Conference Call and Webcast

$DH Financials

Live finance-specific insights

Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025

Definitive Healthcare Announces Timing of Its First Quarter 2025 Financial Results Conference Call and Webcast

Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2024

Recent Analyst Ratings for
$DH

$DH
SEC Filings

$DH
Press Releases

$DH
Financials